These are difficult times for the nation's system of protectionfor human subjects in research.1,2,3,4,5,6,7,8,9,10 On the basisof a series of reports, the Office of the Inspector Generalof the Department of Health and Human Services concluded thatinstitutional review boards (IRBs) are now forced to "reviewtoo much, too quickly, with too little expertise," and withinadequate resources.6 One consequence is that there is minimal,often perfunctory, review of ongoing research. In addition,IRB members have become disillusioned as a result of both publiccriticism concerning the perceived failures of the boards andthe increasing amount of time . . . [Full Text of this Article]
Saginur, R., Dent, S. F., Schwartz, L., Heslegrave, R., Stacey, S., Manzo, J.
(2008). Ontario Cancer Research Ethics Board: Lessons Learned From Developing a Multicenter Regional Institutional Review Board. JCO
26: 1479-1482
[Abstract][Full Text]
Sobolski, G. K., Flores, L., Emanuel, E. J.
(2007). Institutional Review Board Review of Multicenter Studies. ANN INTERN MED
146: 759-759
[Full Text]
McClure, K. B, Delorio, N. M, Schmidt, T. A, Chiodo, G., Gorman, P.
(2007). A qualitative study of institutional review board members' experience reviewing research proposals using emergency exception from informed consent. J. Med. Ethics
33: 289-293
[Abstract][Full Text]
Parvizi, J., Tarity, T. D., Conner, K., Smith, J. B.
(2007). Institutional Review Board Approval: Why It Matters. JBJS
89: 418-426
[Abstract][Full Text]
Brody, B. A., McCullough, L. B., Sharp, R. R.
(2005). Consensus and Controversy in Clinical Research Ethics. JAMA
294: 1411-1414
[Full Text]
(2004). The Ethical Conduct of Clinical Research Involving Critically Ill Patients in the United States and Canada: Principles and Recommendations. Am. J. Respir. Crit. Care Med.
170: 1375-1384
[Full Text]
Emanuel, E. J., Wood, A., Fleischman, A., Bowen, A., Getz, K. A., Grady, C., Levine, C., Hammerschmidt, D. E., Faden, R., Eckenwiler, L., Muse, C. T., Sugarman, J.
(2004). Oversight of Human Participants Research: Identifying Problems To Evaluate Reform Proposals. ANN INTERN MED
141: 282-291
[Abstract][Full Text]
Wolf, S. M., Kahn, J. P., Wagner, J. E.
(2003). Using Preimplantation Genetic Diagnosis to Create a Stem Cell Donor: Issues, Guidelines & limits. J Law Med Ethics
31: 327-339
McWilliams, R., Hoover-Fong, J., Hamosh, A., Beck, S., Beaty, T., Cutting, G.
(2003). Problematic Variation in Local Institutional Review of a Multicenter Genetic Epidemiology Study. JAMA
290: 360-366
[Abstract][Full Text]
Humphreys, K., Trafton, J., Wagner, T. H.
(2003). The Cost of Institutional Review Board Procedures in Multicenter Observational Research. ANN INTERN MED
139: 77-77
[Full Text]
Sung, N. S., Crowley, W. F. Jr, Genel, M., Salber, P., Sandy, L., Sherwood, L. M., Johnson, S. B., Catanese, V., Tilson, H., Getz, K., Larson, E. L., Scheinberg, D., Reece, E. A., Slavkin, H., Dobs, A., Grebb, J., Martinez, R. A., Korn, A., Rimoin, D.
(2003). Central Challenges Facing the National Clinical Research Enterprise. JAMA
289: 1278-1287
[Abstract][Full Text]
Cohen, G. I.
(2003). Clinical Research by Community Oncologists. CA Cancer J Clin
53: 73-81
[Abstract][Full Text]
Emanuel, E. J., Kornfeld, D. S., Mann, H., Paasche-Orlow, M. K., Taggart, J. C.
(2002). Institutional Review Board Reform. NEJM
347: 1285-1286
[Full Text]
Slater, E. E.
(2002). IRB Reform. NEJM
346: 1402-1404
[Full Text]
Steinbrook, R.
(2002). Improving Protection for Research Subjects. NEJM
346: 1425-1430
[Full Text]